U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Sickle cell-beta-thalassemia

Summary

A heterozygous state in which a person has a hemoglobin S allele along with a beta-thalassemia allele. The severity of the condition is determined to a large extent by the quantity of normal hemoglobin produced by the beta-thalassemia gene. [from NCI]

Clinical resources

Practice guidelines

  • ACMG ACT, 2023
    ACMG ACT, Hemoglobin S/Beta Plus Thalassemia , 2023
  • ACMG Algorithm, 2023
    ACMG Algorithm, FSA: Hemoglobin HbS/B+ Screening Result, 2023
  • ACMG ACT, 2012
    American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Sickle Cell Disease, 2012
  • ACMG ACT Sheet, 2010
    American College of Medical Genetics ACT SHEET, Hemoglobin S/Beta plus Thalassemia, 2010
  • ACMG Algorithm, 2009
    American College of Medical Genetics and Genomics, Algorithm, Hb S Screening, 2009

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.